US Stock MarketDetailed Quotes

Reviva Pharmaceuticals (RVPH)

Watchlist
  • 0.8500
  • -0.0240-2.75%
Close Apr 17 16:00 ET
  • 0.8700
  • +0.0200+2.35%
Post 20:01 ET
10.89MMarket Cap-0.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Reviva Pharmaceuticals (RVPH) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
7.14%14.44M
7.14%14.44M
137.16%13.18M
67.75%10.36M
-55.82%5.29M
-42.33%13.48M
-42.33%13.48M
11.80%5.56M
-44.60%6.18M
6.38%11.97M
-Cash and cash equivalents
7.14%14.44M
7.14%14.44M
137.16%13.18M
67.75%10.36M
-55.82%5.29M
-42.33%13.48M
-42.33%13.48M
11.80%5.56M
-44.60%6.18M
6.38%11.97M
Prepaid assets
--0
--0
-91.17%81.74K
-80.25%104.45K
-72.83%211.86K
590.47%540.6K
590.47%540.6K
--925.53K
--528.95K
--779.6K
Other current assets
-0.26%664.69K
-0.26%664.69K
-23.90%247.93K
-34.02%346.96K
1.71%756.07K
161.72%666.44K
161.72%666.44K
-21.44%325.81K
-23.84%525.83K
-54.84%743.38K
Total current assets
2.86%15.1M
2.86%15.1M
98.42%13.51M
49.53%10.82M
-53.64%6.26M
-38.05%14.68M
-38.05%14.68M
26.42%6.81M
-38.92%7.23M
4.61%13.5M
Non current assets
Non current prepaid assets
0.00%819.72K
0.00%819.72K
0.00%819.72K
0.00%819.72K
--819.72K
--819.72K
--819.72K
--819.72K
--819.72K
----
Total non current assets
0.00%819.72K
0.00%819.72K
0.00%819.72K
0.00%819.72K
--819.72K
--819.72K
--819.72K
--819.72K
--819.72K
--0
Total assets
2.71%15.92M
2.71%15.92M
87.85%14.33M
44.48%11.63M
-47.56%7.08M
-34.59%15.5M
-34.59%15.5M
41.63%7.63M
-32.00%8.05M
4.61%13.5M
Liabilities
Current liabilities
Payables
-52.11%3.01M
-52.11%3.01M
-38.12%5.43M
5.87%4.97M
-17.47%4.72M
63.24%6.28M
63.24%6.28M
66.29%8.78M
77.22%4.69M
99.98%5.72M
-accounts payable
-52.11%3.01M
-52.11%3.01M
-38.12%5.43M
5.87%4.97M
-17.47%4.72M
63.24%6.28M
63.24%6.28M
66.29%8.78M
77.22%4.69M
99.98%5.72M
Current accrued expenses
-53.30%3.37M
-53.30%3.37M
-54.80%3.52M
-17.48%6.39M
-16.84%6.01M
-41.59%7.22M
-41.59%7.22M
3.44%7.79M
22.24%7.75M
138.22%7.22M
Current debt and capital lease obligation
-11.19%406.88K
-11.19%406.88K
----
-45.42%113.25K
-32.44%224.3K
--458.15K
--458.15K
-62.70%83K
-6.74%207.5K
-50.26%332K
-Current debt
-11.19%406.88K
-11.19%406.88K
----
-45.42%113.25K
-32.44%224.3K
--458.15K
--458.15K
-62.70%83K
-6.74%207.5K
-50.26%332K
Current liabilities
-50.17%7.28M
-50.17%7.28M
-44.46%9.74M
-13.39%12.08M
-20.58%11.51M
-14.98%14.6M
-14.98%14.6M
34.53%17.53M
51.43%13.94M
120.91%14.49M
Non current liabilities
Derivative product liabilities
--0
--0
-42.86%44.51K
-88.89%16.69K
-92.06%27.82K
-88.97%89.01K
-88.97%89.01K
-91.08%77.88K
-85.16%150.21K
-37.00%350.48K
Total non current liabilities
--0
--0
-42.86%44.51K
-88.89%16.69K
-92.06%27.82K
-88.97%89.01K
-88.97%89.01K
-91.08%77.88K
-85.16%150.21K
-37.00%350.48K
Total liabilities
-50.47%7.28M
-50.47%7.28M
-44.45%9.78M
-14.19%12.09M
-22.27%11.54M
-18.30%14.69M
-18.30%14.69M
26.64%17.61M
37.90%14.09M
108.56%14.84M
Shareholders'equity
Share capital
150.21%11.66K
150.21%11.66K
187.62%9.62K
128.03%6.8K
67.41%4.67K
66.83%4.66K
66.83%4.66K
47.64%3.34K
31.66%2.98K
36.53%2.79K
-common stock
150.21%11.66K
150.21%11.66K
187.62%9.62K
128.03%6.8K
67.41%4.67K
66.83%4.66K
66.83%4.66K
47.64%3.34K
31.66%2.98K
36.53%2.79K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-12.09%-184.14M
-12.09%-184.14M
-14.40%-180.77M
-18.12%-176.76M
-20.40%-170.71M
-22.27%-164.27M
-22.27%-164.27M
-30.91%-158.01M
-35.78%-149.65M
-45.02%-141.79M
Paid-in capital
16.78%192.77M
16.78%192.77M
25.19%185.31M
22.76%176.29M
18.37%166.24M
17.86%165.08M
17.86%165.08M
31.95%148.03M
28.41%143.6M
35.62%140.44M
Total stockholders'equity
964.23%8.65M
964.23%8.65M
145.58%4.55M
92.40%-459.15K
-231.40%-4.46M
-85.79%812.57K
-85.79%812.57K
-17.17%-9.98M
-472.66%-6.04M
-123.26%-1.35M
Total equity
964.23%8.65M
964.23%8.65M
145.58%4.55M
92.40%-459.15K
-231.40%-4.46M
-85.79%812.57K
-85.79%812.57K
-17.17%-9.98M
-472.66%-6.04M
-123.26%-1.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 7.14%14.44M7.14%14.44M137.16%13.18M67.75%10.36M-55.82%5.29M-42.33%13.48M-42.33%13.48M11.80%5.56M-44.60%6.18M6.38%11.97M
-Cash and cash equivalents 7.14%14.44M7.14%14.44M137.16%13.18M67.75%10.36M-55.82%5.29M-42.33%13.48M-42.33%13.48M11.80%5.56M-44.60%6.18M6.38%11.97M
Prepaid assets --0--0-91.17%81.74K-80.25%104.45K-72.83%211.86K590.47%540.6K590.47%540.6K--925.53K--528.95K--779.6K
Other current assets -0.26%664.69K-0.26%664.69K-23.90%247.93K-34.02%346.96K1.71%756.07K161.72%666.44K161.72%666.44K-21.44%325.81K-23.84%525.83K-54.84%743.38K
Total current assets 2.86%15.1M2.86%15.1M98.42%13.51M49.53%10.82M-53.64%6.26M-38.05%14.68M-38.05%14.68M26.42%6.81M-38.92%7.23M4.61%13.5M
Non current assets
Non current prepaid assets 0.00%819.72K0.00%819.72K0.00%819.72K0.00%819.72K--819.72K--819.72K--819.72K--819.72K--819.72K----
Total non current assets 0.00%819.72K0.00%819.72K0.00%819.72K0.00%819.72K--819.72K--819.72K--819.72K--819.72K--819.72K--0
Total assets 2.71%15.92M2.71%15.92M87.85%14.33M44.48%11.63M-47.56%7.08M-34.59%15.5M-34.59%15.5M41.63%7.63M-32.00%8.05M4.61%13.5M
Liabilities
Current liabilities
Payables -52.11%3.01M-52.11%3.01M-38.12%5.43M5.87%4.97M-17.47%4.72M63.24%6.28M63.24%6.28M66.29%8.78M77.22%4.69M99.98%5.72M
-accounts payable -52.11%3.01M-52.11%3.01M-38.12%5.43M5.87%4.97M-17.47%4.72M63.24%6.28M63.24%6.28M66.29%8.78M77.22%4.69M99.98%5.72M
Current accrued expenses -53.30%3.37M-53.30%3.37M-54.80%3.52M-17.48%6.39M-16.84%6.01M-41.59%7.22M-41.59%7.22M3.44%7.79M22.24%7.75M138.22%7.22M
Current debt and capital lease obligation -11.19%406.88K-11.19%406.88K-----45.42%113.25K-32.44%224.3K--458.15K--458.15K-62.70%83K-6.74%207.5K-50.26%332K
-Current debt -11.19%406.88K-11.19%406.88K-----45.42%113.25K-32.44%224.3K--458.15K--458.15K-62.70%83K-6.74%207.5K-50.26%332K
Current liabilities -50.17%7.28M-50.17%7.28M-44.46%9.74M-13.39%12.08M-20.58%11.51M-14.98%14.6M-14.98%14.6M34.53%17.53M51.43%13.94M120.91%14.49M
Non current liabilities
Derivative product liabilities --0--0-42.86%44.51K-88.89%16.69K-92.06%27.82K-88.97%89.01K-88.97%89.01K-91.08%77.88K-85.16%150.21K-37.00%350.48K
Total non current liabilities --0--0-42.86%44.51K-88.89%16.69K-92.06%27.82K-88.97%89.01K-88.97%89.01K-91.08%77.88K-85.16%150.21K-37.00%350.48K
Total liabilities -50.47%7.28M-50.47%7.28M-44.45%9.78M-14.19%12.09M-22.27%11.54M-18.30%14.69M-18.30%14.69M26.64%17.61M37.90%14.09M108.56%14.84M
Shareholders'equity
Share capital 150.21%11.66K150.21%11.66K187.62%9.62K128.03%6.8K67.41%4.67K66.83%4.66K66.83%4.66K47.64%3.34K31.66%2.98K36.53%2.79K
-common stock 150.21%11.66K150.21%11.66K187.62%9.62K128.03%6.8K67.41%4.67K66.83%4.66K66.83%4.66K47.64%3.34K31.66%2.98K36.53%2.79K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -12.09%-184.14M-12.09%-184.14M-14.40%-180.77M-18.12%-176.76M-20.40%-170.71M-22.27%-164.27M-22.27%-164.27M-30.91%-158.01M-35.78%-149.65M-45.02%-141.79M
Paid-in capital 16.78%192.77M16.78%192.77M25.19%185.31M22.76%176.29M18.37%166.24M17.86%165.08M17.86%165.08M31.95%148.03M28.41%143.6M35.62%140.44M
Total stockholders'equity 964.23%8.65M964.23%8.65M145.58%4.55M92.40%-459.15K-231.40%-4.46M-85.79%812.57K-85.79%812.57K-17.17%-9.98M-472.66%-6.04M-123.26%-1.35M
Total equity 964.23%8.65M964.23%8.65M145.58%4.55M92.40%-459.15K-231.40%-4.46M-85.79%812.57K-85.79%812.57K-17.17%-9.98M-472.66%-6.04M-123.26%-1.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -